Quantitative analysis of standardized uptake values (SUV) of metastatic bone lesions in scintigraphy with 99mTcTc-EDDA/HYNIC-Tyr3-octreotide in patients with neuroendocrine tumours

Neuroendocrine tumours (NETs) are a group of cancers that can produce hormones and other metabolically active compounds. The majority of NETs have specific tissue characteristics, such as the expression of somatostatin receptors (SSTR). Metabolic testing with 99mTcTc-EDDA/HYNIC-Tyr3-octreotide (99mTcTc-EDDA/HYNIC-TOC) can be used in patients with NETs to visualize the presence of receptors in different locations of pathological lesions, including the skeletal system. The study aimed to calculate the body weight maximum standardized uptake value (SUVbwmax) of pathological bone lesions and healthy bone tissues, estimate the size of lesions, and identify a relationship between the SUVbwmax of the bone tissues, age and body mass of the study participants.